RE:RE:RE:RE:RE:RE:RE:Cohodes Short Summary
If I recall, the maximum penalty that can be imposed is 10% of the revenues ... althought I might be mistaken. Given the sales mix of Concordia, this would be aroun what, $60 to $70 million?
The fundamental problem is that these medicines are being provided and you can force a Company to roll back prices or impose fines but at the end, if the Company is no longer able to make money (as would be the case if CXR was told to roll back prices say 3 years ago, extremely unlikely and without a precedant, but lets play make believe for a second), and the medicine is no longer available, what will the government do then?